Impact of HIV infection and AIDS on prevalence of type 2 diabetes in South Africa in 2010
BMJ 1999; 318 doi: https://doi.org/10.1136/bmj.318.7194.1351-b (Published 15 May 1999) Cite this as: BMJ 1999;318:1351
- Vanessa R Panz, Research officer (014panz@chiron.wits.ac.za),
- Barry I Joffe, Professor of metabolic medicine
- Carbohydrate and Lipid Metabolism Research Group, Department of Medicine, University of the Witwatersrand Medical School, 7 York Road, Parktown 2193, Johannesburg, South Africa
EDITOR—Many non-communicable diseases are set to increase dramatically during the 21st century. In particular, the prevalence of diabetes mellitus may double from 124 million people worldwide in 1997 to 220 million by 2010.1 Regions with the greatest potential increases are Asia and Africa—precisely the areas with the greatest potential increases in the prevalence of HIV infection and AIDS. The impact of HIV infection and AIDS on the diabetes epidemic is difficult to assess, but we have tried to estimate it for South Africa using population data …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.